trending Market Intelligence /marketintelligence/en/news-insights/trending/e7oeq6dviogccvkysure0a2 content esgSubNav
In This List

Tetra Bio-Pharma CEO moves from interim to permanent

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Tetra Bio-Pharma CEO moves from interim to permanent

Canadian medical cannabis company Tetra Bio-Pharma Inc. has permanently named Guy Chamberland as CEO and chief scientific officer after he assumed the role on an interim basis in April.

Chamberland has been the chief scientific officer and regulatory affairs of Tetra since June 2016.

Orleans, Ontario-based Tetra Bio-Pharma is a development stage medicinal cannabis company, which focuses on developing biopharmaceuticals and natural health products containing cannabis and other medicinal plant-based elements.